These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


789 related items for PubMed ID: 20923719

  • 21. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis.
    Carter BA, Shulman RJ.
    Nat Clin Pract Gastroenterol Hepatol; 2007 May; 4(5):277-87. PubMed ID: 17476210
    [Abstract] [Full Text] [Related]

  • 22. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
    Orso G, Mandato C, Veropalumbo C, Cecchi N, Garzi A, Vajro P.
    Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
    [Abstract] [Full Text] [Related]

  • 23. Elements of successful intestinal rehabilitation.
    Sigalet D, Boctor D, Brindle M, Lam V, Robertson M.
    J Pediatr Surg; 2011 Jan; 46(1):150-6. PubMed ID: 21238657
    [Abstract] [Full Text] [Related]

  • 24. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes.
    Andorsky DJ, Lund DP, Lillehei CW, Jaksic T, Dicanzio J, Richardson DS, Collier SB, Lo C, Duggan C.
    J Pediatr; 2001 Jul; 139(1):27-33. PubMed ID: 11445790
    [Abstract] [Full Text] [Related]

  • 25. Enteral fish oil for treatment of parenteral nutrition-associated liver disease in six infants with short-bowel syndrome.
    Tillman EM, Crill CM, Black DD, Hak EB, Lazar LF, Christensen ML, Huang EY, Helms RA.
    Pharmacotherapy; 2011 May; 31(5):503-9. PubMed ID: 21923431
    [Abstract] [Full Text] [Related]

  • 26. A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis.
    Lam HS, Tam YH, Poon TC, Cheung HM, Yu X, Chan BP, Lee KH, Lee BS, Ng PC.
    Neonatology; 2014 May; 105(4):290-6. PubMed ID: 24576844
    [Abstract] [Full Text] [Related]

  • 27. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease.
    Nandivada P, Cowan E, Carlson SJ, Chang M, Gura KM, Puder M.
    Prostaglandins Leukot Essent Fatty Acids; 2013 Sep; 89(4):153-8. PubMed ID: 23602846
    [Abstract] [Full Text] [Related]

  • 28. Prevention of parenteral nutrition-associated liver disease: lipid minimization.
    Cober MP, Teitelbaum DH.
    Curr Opin Organ Transplant; 2010 Jun; 15(3):330-3. PubMed ID: 20386446
    [Abstract] [Full Text] [Related]

  • 29. [Parenteral nutrition-associated liver disease].
    Moreno Villares JM.
    Nutr Hosp; 2008 May; 23 Suppl 2():25-33. PubMed ID: 18714408
    [Abstract] [Full Text] [Related]

  • 30. Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease.
    Koletzko B, Goulet O.
    Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):321-6. PubMed ID: 20393276
    [Abstract] [Full Text] [Related]

  • 31. Hepatic complications of parenteral nutrition.
    Bower RH.
    Semin Liver Dis; 1983 Aug; 3(3):216-24. PubMed ID: 6414087
    [Abstract] [Full Text] [Related]

  • 32. Intestinal failure-associated liver disease in surgical infants requiring long-term parenteral nutrition.
    Bishay M, Pichler J, Horn V, Macdonald S, Ellmer M, Eaton S, Hill S, Pierro A.
    J Pediatr Surg; 2012 Feb; 47(2):359-62. PubMed ID: 22325390
    [Abstract] [Full Text] [Related]

  • 33. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition.
    Burns DL, Gill BM.
    JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):274-80. PubMed ID: 22683685
    [Abstract] [Full Text] [Related]

  • 34. Early enteral fat supplementation with microlipid® and fish oil in the treatment of two premature infants with short bowel.
    Yang Q, Welch CD, Ayers K, Turner C, Pranikoff T.
    Neonatology; 2010 Mar; 98(4):348-53. PubMed ID: 20980771
    [Abstract] [Full Text] [Related]

  • 35. Liver disease due to parenteral and enteral nutrition.
    Kwan V, George J.
    Clin Liver Dis; 2004 Nov; 8(4):893-913, ix-x. PubMed ID: 15464661
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Parenteral nutrition and hepatobiliary dysfunction.
    Farrell MK, Balistreri WF.
    Clin Perinatol; 1986 Mar; 13(1):197-212. PubMed ID: 3082561
    [Abstract] [Full Text] [Related]

  • 38. Clinical outcome in patients from a single region who were dependent on parenteral nutrition for 28 days or more.
    Köglmeier J, Day C, Puntis JW.
    Arch Dis Child; 2008 Apr; 93(4):300-2. PubMed ID: 18192319
    [Abstract] [Full Text] [Related]

  • 39. Potential usefulness of olive oil-based lipid emulsions in selected situations of home parenteral nutrition-associated liver disease.
    Reimund JM, Arondel Y, Joly F, Messing B, Duclos B, Baumann R.
    Clin Nutr; 2004 Dec; 23(6):1418-25. PubMed ID: 15556265
    [Abstract] [Full Text] [Related]

  • 40. Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children.
    Goulet O, Baglin-Gobet S, Talbotec C, Fourcade L, Colomb V, Sauvat F, Jais JP, Michel JL, Jan D, Ricour C.
    Eur J Pediatr Surg; 2005 Apr; 15(2):95-101. PubMed ID: 15877257
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 40.